Back to today’s briefing

Story perspectives

UK Gyms Surge with New Members from Weight-Loss Drugs

10/26/2025

29 6

Summary

Story summary

In the United Kingdom, gyms report a surge in memberships tied to GLP-1 weight-loss drugs Wegovy and Mounjaro.
The medications can cause muscle loss alongside fat reduction.
Will Orr of the Gym Group says the trend offers an opportunity to attract new members.
Gyms are adding specialized courses to educate staff and members on strength training and protein intake.
Approximately 2.5 million people in Britain use these drugs.

1 of 1

Story summary

In the United Kingdom, gyms report a surge in memberships tied to GLP-1 weight-loss drugs Wegovy and Mounjaro.
The medications can cause muscle loss alongside fat reduction.
Will Orr of the Gym Group says the trend offers an opportunity to attract new members.
Gyms are adding specialized courses to educate staff and members on strength training and protein intake.
Approximately 2.5 million people in Britain use these drugs.